Investors

This section of the website provides financial reports, investor presentations, information on key corporate transactions and much more.

We strive to be transparent, relevant and accurate in presenting our financial information, in order to inform our stakeholders of the company’s operations and financial position.

If you have any questions, please don’t hesitate to contact us at investors@c-rad.com
Svensk version här

Sign up to our newsletter to keep up to date with investor news

Five reasons to invest in C-RAD

  • Contributing to improved cancer care and ultimately saving human life
  • Several factors point towards surface tracking becoming standard of care – which will unleash a vast market potential for C-RAD with exponential revenue growth
  • C-RAD has a proven and recognized product
  • C-RAD has comprehensive market access with a direct sales force, distributors, and direct cooperation with OEM-vendors
  • C-RAD has a stable financial platform – profitable growth, debt free and +100 MSEK in cash
Learn more

Press releases

2026-05-15 09:00 C-RAD and SeeTreat partner to deliver personalised radiotherapy for every patient News Corporate Information Other Corporate Information English Regulatory Listing Regulation IR
2026-05-15 09:00 C-RAD och SeeTreat ingår ett partnerskap för att erbjuda mer individanpassad strålbehandling till varje patient News Corporate Information Other Corporate Information Swedish Regulatory Listing Regulation IR
2026-05-13 09:00 C-RAD markerar sitt nya kapitel på ESTRO 2026 och visar upp klinikdrivna framsteg inom SGRT News Corporate Information Other Corporate Information Swedish IR
2026-05-13 09:00 C-RAD marks its new chapter at ESTRO 2026 with clinician-driven SGRT advances News Corporate Information Other Corporate Information English IR
2026-05-07 17:00 Kommuniké från C-RAD AB (publ):s årsstämma den 7 maj 2026 News Corporate Information General meeting Report of the AGM Swedish Regulatory Listing Regulation IR
2026-05-06 08:00 C-RAD AB:s Delårsrapport Q1'26 News Swedish Regulatory MAR Report Interim Q1 IR

Shares & stock

Please feel free to contact us regarding investments or other financial questions

If you have any questions, please don’t hesitate to contact us